135 related articles for article (PubMed ID: 11064589)
1. [Strategy for diagnosing hematological malignancies--a proposal from hematologists to laboratory medicine].
Miyazaki Y; Kuriyama K
Rinsho Byori; 2000 Aug; 48(8):685-8. PubMed ID: 11064589
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
3. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
4. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
5. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
6. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
Chillón CM; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; Rodríguez MJ; Rodríguez-Salazar MI; Corrales A; Calmuntia MJ; Orfão A; González M; San Miguel JF
Haematologica; 2001 Feb; 86(2):162-6. PubMed ID: 11224485
[TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
10. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics of pediatric acute myeloid leukemia.
Manola KN
Eur J Haematol; 2009 Nov; 83(5):391-405. PubMed ID: 19563518
[TBL] [Abstract][Full Text] [Related]
12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
[TBL] [Abstract][Full Text] [Related]
14. [Morphology and immunophenotyping in hematological malignancies].
Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
[TBL] [Abstract][Full Text] [Related]
15. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
16. Advances in understanding the biology and genetics of acute myelocytic leukemia.
McKenzie SB
Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
19. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
20. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
Kiyoi H
Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]